This construct displayed low affinity to CD71 during blood circulation while increasing its serum half-life and facilitating the loading of Doxorubicin (DOXO), an anthracycline chemotherapy drug, at the tumor site [10,11,12]. Here, TFRC is linked to neoplasm.